<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments for Center for Oncology Research &amp; Treatment--Dallas, TX</title>
	<atom:link href="http://cancernews.wordpress.com/comments/feed/" rel="self" type="application/rss+xml" />
	<link>http://cancernews.wordpress.com</link>
	<description>Innovative Cancer Treatment</description>
	<lastBuildDate>Mon, 16 Nov 2009 13:59:17 +0000</lastBuildDate>
	<generator>http://wordpress.com/</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>Comment on Study Tests Extension of Anti-Her-2 Therapy Beyond Herceptin for Early Stage Breast Cancer Patients by bmirtsching</title>
		<link>http://cancernews.wordpress.com/2009/08/05/study-tests-extension-of-anti-her-2-therapy-beyond-herceptin-for-early-stage-breast-cancer-patients/#comment-378</link>
		<dc:creator>bmirtsching</dc:creator>
		<pubDate>Mon, 16 Nov 2009 13:59:17 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=300#comment-378</guid>
		<description>Lapatinib in the ALTTO study is provided.  The other drugs and care in the ALTTO study are considered routine and standard for adjuvant therapy of her-2+ breast cancer, and those should be covered by insurance.  If you have further questions about coverage or the ALTTO study, please contact my office, or another ALTTO study site (listed at http://clinicaltrials.gov/ct2/show/NCT00490139).</description>
		<content:encoded><![CDATA[<p>Lapatinib in the ALTTO study is provided.  The other drugs and care in the ALTTO study are considered routine and standard for adjuvant therapy of her-2+ breast cancer, and those should be covered by insurance.  If you have further questions about coverage or the ALTTO study, please contact my office, or another ALTTO study site (listed at <a href="http://clinicaltrials.gov/ct2/show/NCT00490139)" rel="nofollow">http://clinicaltrials.gov/ct2/show/NCT00490139)</a>.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Study Tests Extension of Anti-Her-2 Therapy Beyond Herceptin for Early Stage Breast Cancer Patients by Dora</title>
		<link>http://cancernews.wordpress.com/2009/08/05/study-tests-extension-of-anti-her-2-therapy-beyond-herceptin-for-early-stage-breast-cancer-patients/#comment-377</link>
		<dc:creator>Dora</dc:creator>
		<pubDate>Fri, 13 Nov 2009 23:07:48 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=300#comment-377</guid>
		<description>My mom is 50yrs old and was diagnosed with Breast Cancer stage 3 HER2+.
I under stand that just chemo by it&#039;s self will not be as affective as a trial that includes Hereptin and Lapatinib.  Insurance will not cover What can I do to get on a trial that will not include insurance approval.</description>
		<content:encoded><![CDATA[<p>My mom is 50yrs old and was diagnosed with Breast Cancer stage 3 HER2+.<br />
I under stand that just chemo by it&#8217;s self will not be as affective as a trial that includes Hereptin and Lapatinib.  Insurance will not cover What can I do to get on a trial that will not include insurance approval.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on CORT Metastatic Prostate Cancer Symposium by CORT Metastatic Prostate Cancer Symposium « Center for Oncology &#8230; &#124; Cancer Health Wisdom</title>
		<link>http://cancernews.wordpress.com/2009/10/05/cort-metastatic-prostate-cancer-symposium/#comment-368</link>
		<dc:creator>CORT Metastatic Prostate Cancer Symposium « Center for Oncology &#8230; &#124; Cancer Health Wisdom</dc:creator>
		<pubDate>Mon, 05 Oct 2009 23:36:07 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=320#comment-368</guid>
		<description>[...] View post:  CORT Metastatic Prostate Cancer Symposium « Center for Oncology &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] View post:  CORT Metastatic Prostate Cancer Symposium « Center for Oncology &#8230; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on CORT Symposium on Treatment of Her-2+ Breast Cancer by CORT Symposium on Treatment of Her-2+ Breast Cancer</title>
		<link>http://cancernews.wordpress.com/2009/10/05/cort-symposium-on-treatment-of-her-2-breast-cancer/#comment-367</link>
		<dc:creator>CORT Symposium on Treatment of Her-2+ Breast Cancer</dc:creator>
		<pubDate>Mon, 05 Oct 2009 15:25:44 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=317#comment-367</guid>
		<description>[...] View original post here: CORT Symposium on Treatment of Her-2+ Breast Cancer [...]</description>
		<content:encoded><![CDATA[<p>[...] View original post here: CORT Symposium on Treatment of Her-2+ Breast Cancer [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on STRIDE Breast Cancer Study Testing Stimuvax Cancer Vaccine Open at CORT by DennisVega</title>
		<link>http://cancernews.wordpress.com/2009/09/04/stride-breast-cancer-study-testing-stimuvax-cancer-vaccine-open-at-cort/#comment-366</link>
		<dc:creator>DennisVega</dc:creator>
		<pubDate>Wed, 30 Sep 2009 17:22:36 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=308#comment-366</guid>
		<description>I don’t usually reply to posts but I will in this case, great info...I will add a backlink and bookmark your site. Keep up the good work!</description>
		<content:encoded><![CDATA[<p>I don’t usually reply to posts but I will in this case, great info&#8230;I will add a backlink and bookmark your site. Keep up the good work!</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT by bmirtsching</title>
		<link>http://cancernews.wordpress.com/2009/09/04/new-treatment-for-her-2-metastatic-breast-cancer-opens-at-cort/#comment-365</link>
		<dc:creator>bmirtsching</dc:creator>
		<pubDate>Mon, 28 Sep 2009 16:59:30 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=310#comment-365</guid>
		<description>This drug is only available on clinical study, in first-line use (initial therapy).  There is no data about using it in other situations.    Your physicians should be able to point you to trials and/or other therapies for metastatic her-2+ breast cancer.  There are many other standard therapies that are not taxance (taxol, taxotere, abraxane).  

BCM</description>
		<content:encoded><![CDATA[<p>This drug is only available on clinical study, in first-line use (initial therapy).  There is no data about using it in other situations.    Your physicians should be able to point you to trials and/or other therapies for metastatic her-2+ breast cancer.  There are many other standard therapies that are not taxance (taxol, taxotere, abraxane).  </p>
<p>BCM</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT by Yves Paquet</title>
		<link>http://cancernews.wordpress.com/2009/09/04/new-treatment-for-her-2-metastatic-breast-cancer-opens-at-cort/#comment-364</link>
		<dc:creator>Yves Paquet</dc:creator>
		<pubDate>Mon, 28 Sep 2009 15:31:33 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=310#comment-364</guid>
		<description>Hi, mi wife is fighting a old metastatic breast cancer since 2000.
She received a lot of chemo(200), taxotere,herceptin and now, Abraxanne.
With Abraxanne, the cancer did not progres. She tries to come back to taxotere and cancer grow up. 
Is neratinib could be use with abraxanne ? 
I suppose that if it&#039;s possible teh result could be very good.
We are Canadian (québec) and research are always in late here.
I know she won&#039;t abel to receive an other 200 chemo(side effects) and i&#039;m looking to find other solutions. 

The question is : could you help us ? 

Thanks 

Yves Paquet</description>
		<content:encoded><![CDATA[<p>Hi, mi wife is fighting a old metastatic breast cancer since 2000.<br />
She received a lot of chemo(200), taxotere,herceptin and now, Abraxanne.<br />
With Abraxanne, the cancer did not progres. She tries to come back to taxotere and cancer grow up.<br />
Is neratinib could be use with abraxanne ?<br />
I suppose that if it&#8217;s possible teh result could be very good.<br />
We are Canadian (québec) and research are always in late here.<br />
I know she won&#8217;t abel to receive an other 200 chemo(side effects) and i&#8217;m looking to find other solutions. </p>
<p>The question is : could you help us ? </p>
<p>Thanks </p>
<p>Yves Paquet</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on ABCSG-12: Zoledronic Acid (Zometa) Reduces Recurrence of Early Breast Cancer by bmirtsching</title>
		<link>http://cancernews.wordpress.com/2008/11/05/abcsg-12-zoledronic-acid-zometa-reduces-recurrence-of-early-breast-cancer/#comment-363</link>
		<dc:creator>bmirtsching</dc:creator>
		<pubDate>Thu, 17 Sep 2009 12:39:02 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=117#comment-363</guid>
		<description>No, there was no critieria for low bone density to enter the study.  The study was reported in the New England Journal of Medicine on February 12, 2009.  That report did not report the changes in bone density in the treatment groups.  It did note in the discussion that zoledronic acid effectively prevented bone loss in patients receiving adjuvant therapy with aromatase inhibitors.  The detailed information on the bone effects of zoledronic acid in the premenopausal group of women in this study will hopefully be reported separately.</description>
		<content:encoded><![CDATA[<p>No, there was no critieria for low bone density to enter the study.  The study was reported in the New England Journal of Medicine on February 12, 2009.  That report did not report the changes in bone density in the treatment groups.  It did note in the discussion that zoledronic acid effectively prevented bone loss in patients receiving adjuvant therapy with aromatase inhibitors.  The detailed information on the bone effects of zoledronic acid in the premenopausal group of women in this study will hopefully be reported separately.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Bisphosphonate (Zoledronic Acid=Zometa) Improves Adjuvant Endocrine Therapy for Pre-menopausal Breast Cancer Patients; Ongoing CORT Study Assesses Bisphosphonates in Adjuvant Therapy in Broader Groups of Patients by shylove</title>
		<link>http://cancernews.wordpress.com/2008/06/06/bisphosphonate-zoledronic-acidzometa-improves-adjuvant-endocrine-therapy-for-pre-menopausal-breast-cancer-patients-ongoing-cort-study-assesses-bisphosphonates-in-adjuvant-therapy-in-broader-groups/#comment-357</link>
		<dc:creator>shylove</dc:creator>
		<pubDate>Mon, 07 Sep 2009 04:15:08 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=50#comment-357</guid>
		<description>Nice to read this, Thank for your sharing. Very helpfull for me :)</description>
		<content:encoded><![CDATA[<p>Nice to read this, Thank for your sharing. Very helpfull for me <img src='http://s.wordpress.com/wp-includes/images/smilies/icon_smile.gif' alt=':)' class='wp-smiley' /> </p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT by New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT &#8230;</title>
		<link>http://cancernews.wordpress.com/2009/09/04/new-treatment-for-her-2-metastatic-breast-cancer-opens-at-cort/#comment-355</link>
		<dc:creator>New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT &#8230;</dc:creator>
		<pubDate>Sat, 05 Sep 2009 21:19:00 +0000</pubDate>
		<guid isPermaLink="false">http://cancernews.wordpress.com/?p=310#comment-355</guid>
		<description>[...] Go here to read the rest:  New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] Go here to read the rest:  New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT &#8230; [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
